世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ジペプチドペプチダーゼ4(DPP-4)阻害剤の世界市場成長 2024-2030


Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Growth 2024-2030

ジペプチドペプチダーゼ4(DPP-4)阻害薬は、インクレチンと呼ばれる一群の消化管ホルモンを破壊する酵素であるDPP-4の働きを阻害することによって作用する経口糖尿病薬の一種である。インクレチンは、インスリン... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年5月24日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
94 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

ジペプチドペプチダーゼ4(DPP-4)阻害薬は、インクレチンと呼ばれる一群の消化管ホルモンを破壊する酵素であるDPP-4の働きを阻害することによって作用する経口糖尿病薬の一種である。インクレチンは、インスリンが必要な時(例えば食後)にはその分泌を促進し、インスリンが不要な時(例えば消化中)には肝臓によるグルカゴンの分泌を抑える。また、消化を遅らせ、食欲を減退させる。つまり、インクレチンをダメージから守ることで、DPP-4阻害薬は血糖値の調節を助けるのである。
ジペプチドペプチダーゼ4(DPP-4)阻害剤の世界市場規模は、2023年の8億7,880万米ドルから2030年には1億3,070万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は2.4%と予想されている。
LPインフォメーション社の最新調査レポート「ジペプチドペプチダーゼ4(DPP-4)阻害剤産業予測」は、過去の販売実績と2023年の世界のジペプチドペプチダーゼ4(DPP-4)阻害剤総販売実績を調べ、2024年から2030年までのジペプチドペプチダーゼ4(DPP-4)阻害剤販売予測について地域別・市場分野別に包括的に分析しています。ジペプチドペプチダーゼ4(DPP-4)阻害剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界のジペプチドペプチダーゼ4(DPP-4)阻害剤産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界のジペプチドペプチダーゼ4(DPP-4)阻害剤の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また本レポートでは、ジペプチドペプチダーゼ4(DPP-4)阻害剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、世界の主要企業の戦略を分析し、加速する世界のジペプチドペプチダーゼ4(DPP-4)阻害剤市場におけるこれらの企業の独自の地位をより良く理解しています。
本インサイトレポートでは、ジペプチドペプチダーゼ4(DPP-4)阻害剤の世界的な見通しを形成している主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に分けて予測することで、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、本調査予測は世界のジペプチドペプチダーゼ4(DPP-4)阻害剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。
ジャヌビア(シタグリプチン)、ガルバス(ビルダグリプチン)、オングリザ(サキサグリプチン)、トラジェンタ(リナグリプチン)が市場における主要なDPP-4薬である。
本レポートでは、ジペプチドペプチダーゼ4(DPP-4)阻害剤市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会を紹介します。
タイプ別セグメント
シタグリプチン
サキサグリプチン
リナグリプチン
アログリプチン
ビルダグリプチン
用途別セグメント
病院
クリニック
また、本レポートでは地域別に市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
メルク
イーライリリー
アストラゼニカ
ベーリンガーインゲルハイム
武田薬品工業
BMS
本レポートで扱う主な質問
世界のジペプチドペプチダーゼ4(DPP-4)阻害薬市場の10年見通しは?
ジペプチドペプチダーゼ4(DPP-4)阻害剤の世界市場および地域別市場成長の要因は何か?
市場別、地域別で最も急成長する技術は何か?
ジペプチドペプチダーゼ4(DPP-4)阻害剤の市場機会は最終市場規模によってどのように異なるのか?
ジペプチドペプチダーゼ4(DPP-4)阻害剤のタイプ別、用途別内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country/Region, 2019, 2023 & 2030
2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
2.2.1 Sitagliptin
2.2.2 Saxagliptin
2.2.3 Linagliptin
2.2.4 Alogliptin
2.2.5 Vildagliptin
2.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
2.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2019-2024)
2.3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue and Market Share by Type (2019-2024)
2.3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Type (2019-2024)
2.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
2.5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Market Share by Application (2019-2024)
2.5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue and Market Share by Application (2019-2024)
2.5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Application (2019-2024)
3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company
3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
3.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Company (2019-2024)
3.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Company (2019-2024)
3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Company (2019-2024)
3.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Company (2019-2024)
3.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Company (2019-2024)
3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Company
3.4 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Location Distribution
3.4.2 Players Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region
4.1 World Historic Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Geographic Region (2019-2024)
4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country/Region (2019-2024)
4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Country/Region (2019-2024)
4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Country/Region (2019-2024)
4.3 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.4 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.5 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.6 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
5 Americas
5.1 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
5.1.1 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
5.1.2 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
5.2 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
5.3 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region
6.1.1 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2019-2024)
6.1.2 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2019-2024)
6.2 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
6.3 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
7.1.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
7.1.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
7.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
7.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
8.1.1 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
8.1.2 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
8.2 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
8.3 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
10.3 Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
10.4 Industry Chain Structure of Dipeptide Peptidase 4 (DPP-4) Inhibitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
11.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customer
12 World Forecast Review for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region
12.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Region
12.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Region (2025-2030)
12.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Type
12.7 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZenica
13.3.1 AstraZenica Company Information
13.3.2 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AstraZenica Main Business Overview
13.3.5 AstraZenica Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Takeda Pharmaceutical Company
13.5.1 Takeda Pharmaceutical Company Company Information
13.5.2 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Takeda Pharmaceutical Company Main Business Overview
13.5.5 Takeda Pharmaceutical Company Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market size is projected to grow from US$ 8788.8 million in 2023 to US$ 10370 million in 2030; it is expected to grow at a CAGR of 2.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Forecast” looks at past sales and reviews total world Dipeptide Peptidase 4 (DPP-4) Inhibitors sales in 2023, providing a comprehensive analysis by region and market sector of projected Dipeptide Peptidase 4 (DPP-4) Inhibitors sales for 2024 through 2030. With Dipeptide Peptidase 4 (DPP-4) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dipeptide Peptidase 4 (DPP-4) Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Dipeptide Peptidase 4 (DPP-4) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dipeptide Peptidase 4 (DPP-4) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dipeptide Peptidase 4 (DPP-4) Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dipeptide Peptidase 4 (DPP-4) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dipeptide Peptidase 4 (DPP-4) Inhibitors.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Dipeptide Peptidase 4 (DPP-4) Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market?
What factors are driving Dipeptide Peptidase 4 (DPP-4) Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dipeptide Peptidase 4 (DPP-4) Inhibitors market opportunities vary by end market size?
How does Dipeptide Peptidase 4 (DPP-4) Inhibitors break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country/Region, 2019, 2023 & 2030
2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
2.2.1 Sitagliptin
2.2.2 Saxagliptin
2.2.3 Linagliptin
2.2.4 Alogliptin
2.2.5 Vildagliptin
2.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
2.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2019-2024)
2.3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue and Market Share by Type (2019-2024)
2.3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Type (2019-2024)
2.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
2.5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Market Share by Application (2019-2024)
2.5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue and Market Share by Application (2019-2024)
2.5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Application (2019-2024)
3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company
3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
3.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Company (2019-2024)
3.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Company (2019-2024)
3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Company (2019-2024)
3.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Company (2019-2024)
3.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Company (2019-2024)
3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sale Price by Company
3.4 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Location Distribution
3.4.2 Players Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region
4.1 World Historic Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Geographic Region (2019-2024)
4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country/Region (2019-2024)
4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Sales by Country/Region (2019-2024)
4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue by Country/Region (2019-2024)
4.3 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.4 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.5 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
4.6 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth
5 Americas
5.1 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
5.1.1 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
5.1.2 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
5.2 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
5.3 Americas Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region
6.1.1 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2019-2024)
6.1.2 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2019-2024)
6.2 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
6.3 APAC Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
7.1.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
7.1.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
7.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
7.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
8.1.1 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2019-2024)
8.1.2 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2019-2024)
8.2 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
8.3 Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
10.3 Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
10.4 Industry Chain Structure of Dipeptide Peptidase 4 (DPP-4) Inhibitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
11.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customer
12 World Forecast Review for Dipeptide Peptidase 4 (DPP-4) Inhibitors by Geographic Region
12.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Region
12.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Region (2025-2030)
12.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Type
12.7 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZenica
13.3.1 AstraZenica Company Information
13.3.2 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AstraZenica Main Business Overview
13.3.5 AstraZenica Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Takeda Pharmaceutical Company
13.5.1 Takeda Pharmaceutical Company Company Information
13.5.2 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Takeda Pharmaceutical Company Main Business Overview
13.5.5 Takeda Pharmaceutical Company Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolios and Specifications
13.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(inhibitors)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/25 10:25

158.38 円

165.32 円

201.48 円

ページTOPに戻る